Patients May Benefit from Molecular Profiling of Tumor  BRAF, PI3K, etc, would benefit from available drugs

Patients May Benefit from Molecular Profiling of Tumor BRAF, PI3K, etc, would benefit from available drugs

User Photo
moasc

2 years
37 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Santosh Kesari, MD, explains Patients May Benefit from Molecular Profiling of Tumor BRAF, PI3K, etc, would benefit from available drugs at the 2018 Oncology Summit in Huntington Beach, CA

Go to: http://www.moasc.org for more information
Up Next Autoplay